Hip fracture Musculoskeletal Diseases Fracture of neck of femur
Conditions
Interventions
Patients will be randomly assigned a treatment using a web-based randomisation system, this will make sure that about the same number of patients in each participating hospital are assigned each treat
Sponsors
University of Oxford
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Feasibility study: All patients, both those with and without capacity, presenting with an AO type 31-B3 (subcapital, displaced, nonimpacted) fracture of the hip Main phase of the study (added 11/04/2018): All patients aged 60 years and older who have fractured their hip and will receive treatment with a hemiarthroplasty
Exclusion criteria
Exclusion criteria: 1. Younger than 60 years of age 2. Managed non-operatively 3. Treated with a total hip replacement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility study: Recruitment rate, calculated from the number of patients screened and recruited at each participating hospital. Logs of screened and recruited patients monitored monthly. Main phase of the study (added 11/04/2018): Quality of life, measured using the EQ-5D-5L score at 4 months post-randomisation | — |
Secondary
| Measure | Time frame |
|---|---|
| Feasibility study: 1. Quality of life, measured using the EQ-5D-5L questionnaire at baseline (retrospective/pre-injury), 1 month and 4 months after surgery 2. Trial feasibility, assessed by analysing the reasons given by potential patients who chose not to participate (or who later withdraw), monitored continuously throughout the trial 3. Changes in blood pressure during and immediately after surgery, calculated from routinely collected blood pressure measurements Main phase of the study (added 11/04/2018): 1. Quality of life, measured using the EQ-5D-5L at 1 and 12 months post randomisation 2. Mortality, measured using routine NHS data at 1, 4 and 12 months post randomisation 3. Functional status, patient-reported during follow-up at 1, 4 and 12 months post randomisation 4. Incidence and cause of revision surgery, patient-reported and from hospital records during follow-up at 12-months post randomisation 5. Complication profile, patient-reported during follow-up at 12-months post randomisation 6. Residential status, patient-reported during follow-up at 1, 4 and 12 months post randomisation 7. Resource use, patient-reported and from hospital records during follow-up at 12-months post randomisation 8. Blood pressure changes during surgery measured using intra-operative haemodynamic measurements at baseline | — |
Countries
England, United Kingdom
Contacts
Public ContactKaty Mironov
Outcome results
None listed